Asthma Therapeutics: New Treatment Options And Emerging Drug Discovery TargetsLeadDiscoveryApril 1, 2003 SKU: LD1330849 |
|
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a
|
more...
|
$3,995.00
|
|
Cough, Cold and Allergy (Hay Fever) Remedies in Dominican Republic
5/9/2012 | published by: Euromonitor International
Generics’ development through the national government public health programme PROMESE/CAL (Programa de Medicamentos Esenciales y Centro de Apoyo Logístico) during 2011 continued to play an important role in the category. This was because lower-income consumers
|
more...
|
$900.00
|
|
Cough, Cold and Allergy (Hay Fever) Remedies in Guatemala
5/10/2012 | published by: Euromonitor International
In 2011 cough, cold and allergy (hay fever) remedies reached GTQ103 million in current value sales after experiencing growth of 6%. The category is one of the largest in the total consumer health market in
|
more...
|
$900.00
|
|
Cough, Cold and Allergy (Hay Fever) Remedies in Latvia
5/8/2012 | published by: Euromonitor International
Cough, cold and allergy (hay fever) remedies had value growth in 2011. However, the number of influenza cases did not change significantly compared to 2010. Fluctuating temperature in summer resulted in higher sales performance of
|
more...
|
$900.00
|
|
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity
5/15/2012 | published by: GBI Research
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity
Summary
GBI Research, the leading
|
more...
|
$3,500.00
|
|
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
5/21/2012 | published by: GlobalData
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report
|
more...
|
$3,995.00
|
|
Cough, Cold and Allergy (Hay Fever) Remedies in Ukraine
5/10/2012 | published by: Euromonitor International
In Ukraine, self-medication for coughs, colds and allergies is widespread, with consumer knowledge about such medicines boosted by regular TV advertising. While visiting doctors for such ailments is generally avoided due largely to the poor
|
more...
|
$900.00
|
|
Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012 provides data on the Viral Respiratory Tract Infection clinical trial scenario. This
|
more...
|
$1,000.00
|
|
Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments
4/30/2012 | published by: GBI Research
Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments Summary GBI Research, the leading business intelligence provider, has released its latest
|
more...
|
$3,500.00
|
|
Hepatic Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hepatic Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hepatic Injury Global Clinical Trials Review, H1, 2012 provides data on the Hepatic Injury clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
Related Markets
- Diseases & Conditions
- Asthma
- Pharmaceuticals
- Research & Development
- Drug Discovery
- Therapeutic Area
- Respiratory/Pulmonary
- Allergy/Immunology
